PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hospital Universitario Central de Asturias (HUCA), Avda. Roma s/n., 33011, Oviedo, Spain. cannata@hca.es.\', \'Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain. cannata@hca.es.\', \'Universidad de Oviedo, Oviedo, Spain. cannata@hca.es.\', \'Retic REDinREN-ISCIII, Madrid, Spain. cannata@hca.es.\', \'Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.\', \'Centro de Salud Roces Montevil, Gijón, Spain.\', \'Hospital Privado Universitario de Córdoba, Córdoba, Argentina.\', \'Hospital Raúl Ángel Ferreyra, Córdoba, Argentina.\', \'Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba, Argentina.\', \'Hospital Universitario Central de Asturias (HUCA), Avda. Roma s/n., 33011, Oviedo, Spain.\', \'Universidad de Oviedo, Oviedo, Spain.\', \'Hospital Universitario El Bierzo, Ponferrada, Spain.\', \'Retic REDinREN-ISCIII, Madrid, Spain.\', \'Hospital Independencia, Santiago del Estero, Argentina.\', \'Instituto de Nefrología Pergamino SRL, Pergamino, Argentina.\', \'Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Buenos Aires, Argentina.\', \'Hospital General de Enfermedades del Instituto Guatemalteco de Seguridad Social (IGSS), Ciudad de Guatemala, Guatemala.\', \'Hospital Barros Luco Trudeau, Santiago, Chile.\', \'Universidad de Chile, Santiago, Chile.\', \'Hospital Universitario San Agustín (HUSA), Avilés, Spain.\', \'Hospital Lucus Augusti, Lugo, Spain.\', \'Hospital Julio C. Perrando, Resistencia, Argentina.\', \'Centre for Nephrology, Royal Free Hospital and University College London, London, UK.\', \'Hospital Universitario Central de Asturias (HUCA), Avda. Roma s/n., 33011, Oviedo, Spain. mnaves.huca@gmail.com.\', \'Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain. mnaves.huca@gmail.com.\', \'Retic REDinREN-ISCIII, Madrid, Spain. mnaves.huca@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12916-022-02290-8
?:hasPublicationType
?:journal
  • BMC medicine
is ?:pmid of
?:pmid
?:pmid
  • 35177066
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.219
?:rankingScore_hIndex
  • 98
is ?:relation_isRelatedTo_publication of
?:title
  • A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35177066>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35177066>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all